BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma

The BRAF mutation occurs commonly in papillary thyroid carcinoma (PTC). Previous investigations of its utility to predict recurrence-free survival (RFS) and disease-specific survival (DSS) have reported conflicting results and its role remains unclear. The purpose of this retrospective study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Henke, Lauren E, Pfeifer, John D, Ma, Changquing, Perkins, Stephanie M, DeWees, Todd, El-Mofty, Samir, Moley, Jeffrey F, Nussenbaum, Brian, Haughey, Bruce H, Baranski, Thomas J, Schwarz, Julie K, Grigsby, Perry W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472201/
https://www.ncbi.nlm.nih.gov/pubmed/25712893
http://dx.doi.org/10.1002/cam4.417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472201/
https://www.ncbi.nlm.nih.gov/pubmed/25712893
http://dx.doi.org/10.1002/cam4.417

Ejemplares similares